Clarion Announces Launch of Speaker Series

November 7, 2011 – Clarion is pleased to announce the launch of the “Clarion Speaker Series.”  The Speaker Series brings outside experts into Clarion on an ongoing basis to share their perspectives and stimulate discussion and thinking on issues that are critical to Clarion, its clients, and the healthcare industry. Speakers include CEOs, drug development experts, nationally recognized physicians, health quality improvement strategists, regulation and reimbursement experts, and others. Clarion launched the program on November 4th, with Jason Rhodes, EVP and Chief Business officer of Epizyme. Mr. Rhodes spoke about personalized medicine and its impact on drug development.

For more information about Epizyme, click here.